Related Experiment Video
Updated: Aug 9, 2026

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
Published on: October 30, 2018
Epidemiology of rubella in Finland
I Davidkin1, H Peltola, P Leinikki
1National Public Health Institute (KTL), Helsinki, Finland.
Abstract:
Before rubella vaccination programmes began, rubella infection was prevalent in Finnish children. The disease occurred as epidemics at intervals of a few years. Rubella infection was most often contracted between the ages of 2 and 12 years. Vaccinations specifically aimed at eradicating rubella were begun with monocomponent vaccine in the mid-1970s, and the measles, mumps and rubella (MMR) vaccination programme with two injections got underway in 1982. A clear reduction in rubella cases was evident a few years after the launch of the MMR programme. Owing to a sufficiently high vaccination coverage (>95% since 1987), circulation of the indigenous rubella virus in the Finnish population ceased in the late 1990s. Some rubella cases have been imported to Finland since elimination, but they have not caused any secondary cases. This shows unambiguously that protection against rubella continues to be effective, although our cohort studies imply that the vaccine induced antibody levels do decrease with time. The MMR programme has also eliminated congenital rubella syndrome (CRS) from the country. The last CRS case was recorded in 1986. As a result of the high coverage two dose MMR vaccination programme, rubella was successfully eliminated from Finland. How long the acquired protection will last remains to be seen.
Insights
Finland successfully eliminated rubella through its high-coverage measles, mumps, and rubella (MMR) vaccination program. This initiative has also eradicated congenital rubella syndrome, demonstrating vaccine effectiveness.
Area of Science:
- Immunology
- Epidemiology
- Public Health
Background:
- Rubella was historically endemic in Finnish children, causing periodic epidemics.
- Rubella infection commonly occurred in children aged 2-12 years before vaccination.
- Disease surveillance indicated epidemic cycles occurring every few years.
Purpose of the Study:
- To evaluate the long-term impact of rubella vaccination programs in Finland.
- To assess the effectiveness of the measles, mumps, and rubella (MMR) vaccination program in disease elimination.
- To determine the cessation of indigenous rubella virus circulation and congenital rubella syndrome (CRS) incidence.
Main Methods:
- Analysis of historical rubella incidence data before and after vaccination introduction.
- Monitoring of vaccination coverage rates from the mid-1970s onwards.
- Surveillance of imported rubella cases and secondary infections post-elimination.
- Cohort studies to assess vaccine-induced antibody levels over time.
Main Results:
- Rubella cases significantly reduced following the MMR vaccination program launch in 1982.
- Indigenous rubella virus circulation ceased in Finland by the late 1990s due to sustained high vaccination coverage (>95%).
- Congenital rubella syndrome (CRS) was eliminated, with the last case in 1986.
- Imported rubella cases did not result in secondary transmission, indicating effective population immunity.
- Cohort studies suggest a gradual decrease in vaccine-induced antibody levels over time.
Conclusions:
- The high-coverage, two-dose MMR vaccination program successfully eliminated rubella and congenital rubella syndrome in Finland.
- Sustained population immunity effectively prevents sustained transmission of indigenous rubella virus.
- Ongoing monitoring is necessary to ascertain the duration of vaccine-induced protection.
Related Concept Videos
Vaccinations
Infectious Diseases and Their Occurrence
Rocky Mountain Spotted Fever
Poliomyelitis
Influenza
Respiratory Syncytial Virus Disease

